Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03702244 · ClinicalTrials.gov registry record · NA
The PRECISE Protocol: Prospective Randomized Trial of the Optimal Evaluation of Cardiac Symptoms and Revascularization
A NA study, sponsored by HeartFlow.
- Completed
- Registry status
- NA
- Development phase
- 2,103
- Enrollment target
NCT03702244 is a NA study that has completed, run by HeartFlow. The registered enrollment target is 2,103 participants.
The verdict
NCT03702244, a NA study, has completed, sponsored by HeartFlow.
- COMPLETED
- Registry status
- NA
- Development phase
- 2,103 participants
- Enrollment target
Study Summary
The study will be a prospective, pragmatic, randomized clinical trial of the comparative effectiveness of diagnostic evaluation strategies for stable CAD, to be performed in outpatient settings, including primary care and cardiology practices.
Interventions
- DIAGNOSTIC_TEST cCTA with selective FFRct
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,103 participants |
| Start Date | 2018-11-27 |
| Est. Completion | 2022-05-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03702244
The ClinicalTrials.gov registry entry for NCT03702244 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 2,103 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is HeartFlow, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which cCTA with selective FFRct is the first listed.
NCT03702244 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03702244 about?
NCT03702244 is a clinical study titled "The PRECISE Protocol: Prospective Randomized Trial of the Optimal Evaluation of Cardiac Symptoms and Revascularization". The study will be a prospective, pragmatic, randomized clinical trial of the comparative effectiveness of diagnostic evaluation strategies for stable CAD, to be performed in outpatient settings, including primary care and cardiology practices.
What is the current status of trial NCT03702244?
This trial is currently completed. It is a NA study. The enrollment target is 2,103 participants. The study started on 2018-11-27. Estimated completion is 2022-05-20.
What interventions are being tested in trial NCT03702244?
The interventions under investigation include: cCTA with selective FFRct (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03702244?
This trial is sponsored by HeartFlow, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.